Aisling Capital Partners III LLC

FollowCreate a free account to set a filing alert.

10% owner at Zeltiq Aesthetics Inc · on record since Oct 25, 2011
10% owner at Durata Therapeutics, Inc. · on record since Jul 25, 2012
10% owner at ASENSUS SURGICAL, INC. · on record since Sep 5, 2013
10% owner at Aravive, Inc. · on record since Mar 27, 2014
10% owner at AGILE THERAPEUTICS INC · on record since May 28, 2014
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at T2 Biosystems, Inc. · on record since Aug 14, 2014
Director at AGILE THERAPEUTICS INC · on record since Jan 27, 2015
Former 10% Owner at ASENSUS SURGICAL, INC. · on record since Feb 5, 2016
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016

Insider trading activity of Aisling Capital Partners III LLC

Transactions on record: 18; since Jul 25, 2012

Purchases: 7; $32.2M

Sales: 1; $20.1M

Companies traded: 6; last filing Dec 20, 2017

Figures computed from official regulatory filings — .

Companies where Aisling Capital Partners III LLC has traded

Loxo Oncology, Inc.5 tx · $34.3M · Dec 20, 2017
Syros Pharmaceuticals, Inc.3 tx · $5M · Jul 6, 2016
AGILE THERAPEUTICS INC1 tx · Jun 3, 2016
T2 Biosystems, Inc.1 tx · $3M · Dec 9, 2015
Zeltiq Aesthetics Inc5 tx · Jan 27, 2014
3 tx · $10M · Jul 25, 2012

Track record of Aisling Capital Partners III LLC

Statistical track record

Free account

Purchases: 7

Last buy: Jul 6, 2016

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Aisling Capital Partners III LLC

Co-insiders of Aisling Capital Partners III LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Loxo Oncology, Inc.Listing unverified	Dec 20, 2017	Sell	-250,000	80.50 USD	$20.1M		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 6, 2016	Buy	400,000	12.50 USD	$5M	conv 48Cluster	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 6, 2016	OtherD (derivative)	-1,907,122	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 6, 2016	Other	508,565	—	n/a (No price was disclosed in the filing)		SEC
AGILE THERAPEUTICS INCListing unverified	Jun 3, 2016	Other	-400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Loxo Oncology, Inc.Listing unverified	May 19, 2016	Buy	232,558	21.50 USD	$5M	conv 18	SEC
T2 Biosystems, Inc.Listing on record	Dec 9, 2015	Buy	307,692	9.75 USD	$3M	conv 37Cluster	SEC
Loxo Oncology, Inc.Listing unverified	Nov 19, 2015	Buy	265,000	26.50 USD	$7M	conv 16	SEC
Loxo Oncology, Inc.Listing unverified	Nov 16, 2015	Buy	76,714	27.65 USD	$2.1M	conv 34First in 12mo	SEC
Loxo Oncology, Inc.Listing unverified	Nov 16, 2015	Buy	1,955	27.47 USD	$53.7K	conv 10	SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	2,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	-4,715	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	-994,305	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	1,152	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	4,697	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Durata Therapeutics, Inc.Listing unverified	Jul 25, 2012	Buy	1,111,111	9.00 USD	$10M	conv 62ClusterFirst in 12mo	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 25, 2012	OtherD (derivative)	-16,157,707	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Durata Therapeutics, Inc.Listing unverified	Jul 25, 2012	Other	2,019,713	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Loxo Oncology, Inc.Listing unverified	Dec 20, 2017	Sell	-250,000	80.50 USD	$20.1M		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 6, 2016	Buy	400,000	12.50 USD	$5M	conv 48Cluster	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 6, 2016	OtherD (derivative)	-1,907,122	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 6, 2016	Other	508,565	—	n/a (No price was disclosed in the filing)		SEC
AGILE THERAPEUTICS INCListing unverified	Jun 3, 2016	Other	-400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Loxo Oncology, Inc.Listing unverified	May 19, 2016	Buy	232,558	21.50 USD	$5M	conv 18	SEC
T2 Biosystems, Inc.Listing on record	Dec 9, 2015	Buy	307,692	9.75 USD	$3M	conv 37Cluster	SEC
Loxo Oncology, Inc.Listing unverified	Nov 19, 2015	Buy	265,000	26.50 USD	$7M	conv 16	SEC
Loxo Oncology, Inc.Listing unverified	Nov 16, 2015	Buy	76,714	27.65 USD	$2.1M	conv 34First in 12mo	SEC
Loxo Oncology, Inc.Listing unverified	Nov 16, 2015	Buy	1,955	27.47 USD	$53.7K	conv 10	SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	2,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	-4,715	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	-994,305	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	1,152	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Jan 27, 2014	Other	4,697	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Durata Therapeutics, Inc.Listing unverified	Jul 25, 2012	Buy	1,111,111	9.00 USD	$10M	conv 62ClusterFirst in 12mo	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 25, 2012	OtherD (derivative)	-16,157,707	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Durata Therapeutics, Inc.Listing unverified	Jul 25, 2012	Other	2,019,713	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC